[Critical evaluation of a long acting bronchodilator agent in the treatment of asthma and chronic bronchial diseases].
D001249:Asthma / Q000188:drug therapy*; D001982:Bronchial Diseases / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004809:Ephedrine / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D010634:Phenobarbital / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced; D013806:Theophylline / Q000627:therapeutic use*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
D001993:Bronchodilator Agents; D004338:Drug Combinations; D013806:Theophylline; D004809:Ephedrine; D010634:Phenobarbital
Etude critique d'une broncho-dilatation à effet prolongé dans le traitement de l'asthme et des bronchopathies chroniques